Since Acting USPTO Director Coke Morgan Stewart took office in 2025, the Patent Trial and Appeal Board (PTAB) has overhauled its discretionary denial procedures for inter partes reviews (IPRs) and ...
An expert Q&A on the US Patent and Trademark Office’s (USPTO’s) 2025 guidance memoranda addressing the Patent Trial and Appeal Board’s (PTAB’s) approach to discretionary denials of inter partes review ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results